Johnson & Johnson Physiomesh — Product liability contingency, number of claimants decreased by 8.3% to $110.00 in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 31.3%, from $160.00 to $110.00. Over 2 years (FY 2021 to FY 2024), Physiomesh — Product liability contingency, number of claimants shows a downward trend with a -79.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates expanding legal exposure and potential future financial liabilities, while a decrease suggests the litigation volume is stabilizing or resolving.
Represents the total count of individual plaintiffs asserting legal claims against the company related to the Physiomesh...
Comparable to mass tort litigation counts in the pharmaceutical and medical device sectors, such as hernia mesh or pelvic mesh litigation at peer companies.
jnj_segment_physiomesh_product_liability_contingency_number_of_claimants| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.60K | $4.60K | $4.70K | $4.70K | $4.80K | $4.70K | $2.10K | $2.07K | $720.00 | $370.00 | $230.00 | $170.00 | $160.00 | $130.00 | $140.00 | $120.00 | $110.00 |
| QoQ Change | — | +27.8% | +2.2% | +0.0% | +2.1% | -2.1% | -55.3% | -1.4% | -65.2% | -48.6% | -37.8% | -26.1% | -5.9% | -18.8% | +7.7% | -14.3% | -8.3% |
| YoY Change | — | — | — | — | +33.3% | +2.2% | -55.3% | -56.9% | -84.7% | -82.4% | — | -91.8% | -77.8% | -64.9% | -39.1% | -29.4% | -31.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.